ATE314073T1 - Kombination von aktiva mit alfuzosin und apomorphin - Google Patents
Kombination von aktiva mit alfuzosin und apomorphinInfo
- Publication number
- ATE314073T1 ATE314073T1 AT02711823T AT02711823T ATE314073T1 AT E314073 T1 ATE314073 T1 AT E314073T1 AT 02711823 T AT02711823 T AT 02711823T AT 02711823 T AT02711823 T AT 02711823T AT E314073 T1 ATE314073 T1 AT E314073T1
- Authority
- AT
- Austria
- Prior art keywords
- alfuzosine
- apomorphine
- combination
- actives
- ameliorating
- Prior art date
Links
- WNMJYKCGWZFFKR-UHFFFAOYSA-N alfuzosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(C)CCCNC(=O)C1CCCO1 WNMJYKCGWZFFKR-UHFFFAOYSA-N 0.000 title abstract 2
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 title abstract 2
- 229960004046 apomorphine Drugs 0.000 title abstract 2
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Glass Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01400166A EP1224933A1 (de) | 2001-01-19 | 2001-01-19 | Neue Kombination mit Alfuzosin und Apomorphin als Aktiva |
| PCT/EP2002/001051 WO2002056887A1 (en) | 2001-01-19 | 2002-01-18 | New combination of active ingredients containing alfuzosine and apomorphine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE314073T1 true ATE314073T1 (de) | 2006-01-15 |
Family
ID=8182601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02711823T ATE314073T1 (de) | 2001-01-19 | 2002-01-18 | Kombination von aktiva mit alfuzosin und apomorphin |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040063736A1 (de) |
| EP (2) | EP1224933A1 (de) |
| JP (1) | JP2004517141A (de) |
| AT (1) | ATE314073T1 (de) |
| DE (1) | DE60208336T2 (de) |
| DK (1) | DK1355650T3 (de) |
| ES (1) | ES2254657T3 (de) |
| PT (1) | PT1355650E (de) |
| SI (1) | SI1355650T1 (de) |
| WO (1) | WO2002056887A1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
| EP0978282B1 (de) * | 1994-04-22 | 2005-12-14 | Pentech Pharmaceuticals, Inc. | Sublinguale Zusammensetzung enthaltend Apomorphine zur Diagnose der funktionellen Impotenz |
| US6043252A (en) * | 1997-05-05 | 2000-03-28 | Icos Corporation | Carboline derivatives |
| EP1027054A4 (de) * | 1997-10-28 | 2002-11-04 | Vivus Inc | Lokale anwendung von phosphodiesterase inhibitoren zur behandlung der erektilen dysfunktion |
-
2001
- 2001-01-19 EP EP01400166A patent/EP1224933A1/de not_active Withdrawn
-
2002
- 2002-01-18 ES ES02711823T patent/ES2254657T3/es not_active Expired - Lifetime
- 2002-01-18 DK DK02711823T patent/DK1355650T3/da active
- 2002-01-18 DE DE60208336T patent/DE60208336T2/de not_active Expired - Fee Related
- 2002-01-18 EP EP02711823A patent/EP1355650B1/de not_active Expired - Lifetime
- 2002-01-18 WO PCT/EP2002/001051 patent/WO2002056887A1/en not_active Ceased
- 2002-01-18 JP JP2002557394A patent/JP2004517141A/ja active Pending
- 2002-01-18 US US10/466,595 patent/US20040063736A1/en not_active Abandoned
- 2002-01-18 SI SI200230284T patent/SI1355650T1/sl unknown
- 2002-01-18 PT PT02711823T patent/PT1355650E/pt unknown
- 2002-01-18 AT AT02711823T patent/ATE314073T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2254657T3 (es) | 2006-06-16 |
| EP1224933A1 (de) | 2002-07-24 |
| JP2004517141A (ja) | 2004-06-10 |
| EP1355650A1 (de) | 2003-10-29 |
| WO2002056887A1 (en) | 2002-07-25 |
| US20040063736A1 (en) | 2004-04-01 |
| SI1355650T1 (sl) | 2006-06-30 |
| DE60208336D1 (de) | 2006-02-02 |
| DE60208336T2 (de) | 2006-09-07 |
| EP1355650B1 (de) | 2005-12-28 |
| DK1355650T3 (da) | 2006-05-15 |
| PT1355650E (pt) | 2006-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60127277D1 (de) | Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert | |
| TW200626526A (en) | Pharmaceutical compositions for the treatment of neoplasms | |
| DK1411932T3 (da) | Kombinationsterapi med substituerede oxazolidinoner | |
| DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
| BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| DK1363608T3 (da) | Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser | |
| AR034231A1 (es) | Composicion farmaceutica que contiene mosaprida y pancreatina | |
| EA200300929A1 (ru) | Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv | |
| DK1411938T3 (da) | Anvendelse af cyclopamin til fremstilling af et medikament til behandling af psoriasis | |
| EA200501690A1 (ru) | Композиция, включающая ингибитор pde4 и ингибитор pde5 | |
| ATE495793T1 (de) | Antitumorzusammensetzungen welche ecteinascidin 743 enthalten | |
| TR200502508T2 (tr) | IL-18 İnhibitörlerinin kullanımı. | |
| DE69932510D1 (de) | Vaskularisierungsinhibitoren | |
| DE60132851D1 (de) | Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension | |
| DE69803773D1 (de) | Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion | |
| EE200200087A (et) | Kompositsioon hepatotsellulaarse kartsinoomi raviks | |
| EE05211B1 (et) | Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluhirete, kohanemishirete v?i segatpi rev-depressiivsete hirete raviks v?i vltimiseks kasulike ravimite valmistamiseks | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| EA200400436A1 (ru) | Медикаменты для профилактики и лечения бромидроза | |
| MX9403032A (es) | Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos. | |
| DE60213234D1 (de) | 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts | |
| SE0001916D0 (sv) | Novel formulation | |
| ATE314073T1 (de) | Kombination von aktiva mit alfuzosin und apomorphin | |
| SE0000303D0 (sv) | Novel compounds | |
| WO2003045428A3 (de) | Verwendung einer technisch veränderten zelle als vakzine zur behandlung einer tumorerkrankung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1355650 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |